Leiden, The Netherlands, November 26, 2008. Biotech company Pharming Group NV (”Pharming“) (NYSE Euronext: PHARM) announced today that its wholly owned subsidiary DNage has successfully completed a Phase I trial, in healthy human volunteers, to

PHARMING announces positive results from Prodarsan phase i study - PharmiWeb
Leiden, The Netherlands, November 26, 2008. Biotech company Pharming Group NV ( Pharming ) (NYSE Euronext: PHARM) announced today that its wholly owned subsidiary DNage has successfully completed a Phase I trial, in healthy human

Pharming says anti-age drug completes Phase I study - Guardian Unlimited
AMSTERDAM, Nov 26 (Reuters) - Dutch biotechnology firm Pharming Group NV has completed a Phase I study of Prodarsan, a drug made by a subsidiary for those suffering from Cockayne syndrome or premature ageing. Shares in Pharming, which had traded flat

From phishing scams to pharming - Security Park
Recent press abounds with new, innovative spam and phishing attacks. For years it was just email that organisations had to fear, but this has changed rapidly with attacks now appearing from all directions. Instant messaging, message boards

Pharming announces positive results from Prodarsan phase i study Key - Phramalive.com
Leiden, The Netherlands, November 26, 2008. Biotech company Pharming Group NV ( Pharming ) (NYSE Euronext: PHARM) announced today that its wholly owned subsidiary DNage has successfully completed a Phase I trial, in healthy human volunteers, to

Pharming announces change in composition of Board Of Supervisory - StreetInsider.com
LEIDEN, NETHERLANDS — (MARKET WIRE) — 12/01/08 — Leiden, The Netherlands, December 1, 2008. Biotech company Pharming Group NV (”Pharming” or “The Company”) (Euronext: PHARM ) announced today that Prof. Dr. B.P.Th. Veltman has notified the Company

Pharming announces positive results from Prodarsan Phase I Study - Market Wire
Leiden, The Netherlands, November 26, 2008. Biotech company Pharming Group NV (”Pharming“) (NYSE Euronext: PHARM) announced today that its wholly owned subsidiary DNage has successfully completed a Phase I trial, in healthy human volunteers, to

Pharming completes Phase I study of anti-age drug - Pharmaceutical Business Review
In this Phase I study, single and multiple escalating doses were administered to healthy volunteers. The data obtained show that Prodarsan is safe and well tolerated when used in dosages that have earlier shown to yield positive effects in

Balancing Good And Evil - Forbes
Physical crime may not pay, but cybercrime certainly does–and it pays big for those with the know how to take advantage of it. Moreover, in some countries where technology is still in its infancy and laws don’t exist or are only vaguely defined, it

UPDATE 1-Pharming says anti-age drug completes Phase I study - Forbes
AMSTERDAM, Nov 26 (Reuters) - Dutch biotechnology firm Pharming Group NV has completed a Phase I study of Prodarsan, a drug made by a subsidiary for those suffering from Cockayne syndrome or premature ageing. Shares in Pharming, which had traded flat

Tags: